The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Heart Failure
Abstract
There is a high frequency of heart failure (HF) accompanied by an increased mortality risk for patients with diabetes. The poor prognosis of these patients has been explained by an underlying diabetic cardiomyopathy exacerbated by hypertension and ischemic heart disease. In these patients, activation of the sympathetic nervous system results in increased myocardial utilization of fatty acids and induction of fetal gene programs, decreasing myocardial function. Activation of the renin-angiotensin system results in myocardial remodeling. It is imperative for physicians to intercede early to stop the progression of HF, yet at least half of patients with left ventricular dysfunction remain undiagnosed and untreated until advanced disease causes disability. This delay is largely because of the asymptomatic nature of early HF, which necessitates more aggressive assessment of HF risk factors and early clinical signs. Utilization of β-blockade, ACE inhibitors, or possibly angiotensin receptor blockers is essential in preventing remodeling with its associated decline in ventricular function. β-Blockers not only prevent, but may also reverse, cardiac remodeling. Glycemic control may also play an important role in the therapy of diabetic HF. The adverse metabolic side effects that have been associated with β-adrenergic inhibitors in the diabetic patient may be circumvented by use of a third-generation β-blocker. Prophylactic utilization of ACE inhibitors and β-blockers to avoid, rather than await, the need to treat HF should be considered in high-risk diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Malmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Biochemical detection of left-ventricular systolic dysfunction
McDonagh, T., Robb, S., Murdoch, D., Morton, J., Ford, I., Morrison, C., Tunstall-Pedoe, H., McMurray, J., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 963
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 866
Bittner, V. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510140062030 · Cited by 711
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A., Liu, J. Y., Sidney, S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 710
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01682-5 · Cited by 691
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Circulation · doi:10.1161/hc3801.097475 · Cited by 661
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
McDonagh, T. A., Morrison, C. E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 630
Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes
Poirier, P., Bogaty, P., Garneau, C., Marois, L., & Dumesnil, J.-G. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.5 · Cited by 612
Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Hillier, T. A., Erbey, J. R., & Brown, J. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1614 · Cited by 600
Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., Turi, Z. G., Strauss, H. W., Willerson, J. T., Robertson, T., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90053-3 · Cited by 516
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias
Oliver, E. F., & Opie, L. H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90939-3 · Cited by 508
Myocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., Wolfel, E. E., Lindenfeld, J., Tsvetkova, T., Robertson, A. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012630 · Cited by 501
Eichhorn, E. J., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2285 · Cited by 468
Thiazolidinediones: a new class of antidiabetic drugs
Day, C. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00023.x · Cited by 436
Evans, J. M. M., Wang, J., & Morris, A. D. (2002) · BMJ · doi:10.1136/bmj.324.7343.939 · Cited by 392
Cardiac myocyte necrosis induced by angiotensin II.
Tan, L. B., Jalil, J. E., Pick, R., Janicki, J. S., & Weber, K. T. (1991) · Circulation Research · doi:10.1161/01.res.69.5.1185 · Cited by 384
Olsen, S. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D., & Bristow, M. R. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00012-s · Cited by 373
Natural history and patterns of current practice in heart failure
Bourassa, M. G., Gurné, O., Bangdiwala, S. I., Ghali, J. K., Young, J. B., Rousseau, M., Johnstone, D. E., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90456-b · Cited by 361
Linz, W., Schölkens, B. A., & Ganten, D. (1989) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968909038172 · Cited by 336
Lowes, B. D., Gill, E. A., Abraham, W. T., Larrain, J.-R., Robertson, A. D., Bristow, M. R., & Gilbert, E. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00059-4 · Cited by 318
Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs
Mjøs, O. D. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106621 · Cited by 309
Sharpe, N., Smith, H., Murphy, J., Greaves, S., Hart, H., & Gamble, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90202-z · Cited by 308
Giugliano, D., Acampora, R., Marfella, R., De Rosa, N., Ziccardi, P., Ragone, R., De Angelis, L., & D'Onofrio, F. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00004 · Cited by 302
Marantz, P. R., Tobin, J. N., Wassertheil-Smoller, S., Steingart, R. M., Wexler, J. P., Budner, N., Lense, L., & Wachspress, J. (1988) · Circulation · doi:10.1161/01.cir.77.3.607 · Cited by 295
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy
Ganguly, P. K., Pierce, G. N., Dhalla, K. S., & Dhalla, N. S. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.244.6.e528 · Cited by 286
Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., & on behalf of the DIGAMI study group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015067 · Cited by 281
Mitchell, G. F., Lamas, G. A., Vaughan, D. E., & Pfeffer, M. A. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90314-d · Cited by 275
Preclinical abnormality of left ventricular function in diabetes mellitus
Ahmed, S. S., Jaferi, G. A., Narang, R. M., & Regan, T. J. (1975) · American Heart Journal · doi:10.1016/0002-8703(75)90039-3 · Cited by 268
Cardiovascular injury induced by sympathetic catecholamines
Haft, J. I. (1974) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(74)90039-5 · Cited by 264
Stone, P. H., Raabe, D. S., Jaffe, A. S., Gustafson, N., Muller, J. E., Turi, Z. G., Rutherford, J. D., Poole, W. K., Passamani, E., Willerson, J. T., et al. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)91517-3 · Cited by 252
Reis, S. E., Holubkov, R., Edmundowicz, D., McNamara, D. M., Zell, K. A., Detre, K. M., & Feldman, A. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00214-3 · Cited by 249
Zuanetti, G., Latini, R., Maggioni, A. P., Franzosi, M., Santoro, L., & Tognoni, G. (1997) · Circulation · doi:10.1161/01.cir.96.12.4239 · Cited by 235
Clinical and morphological features of human hypertensive-diabetic cardiomyopathy
Factor, S. M., Minase, T., & Sonnenblick, E. H. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90379-8 · Cited by 235
Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?
Bell, D. S. H. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.708 · Cited by 235
Self-citationThe Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart
Katz, A. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-5-199409010-00009 · Cited by 210
Amato, L., Paolisso, G., Cacciatore, F., Ferrara, N., Ferrara, P., Canonico, S., Varricchio, M., & Rengo, F. (1997) · PubMed · Cited by 193
[Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells
Aceto, J. F., & Baker, K. M. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.258.3.h806 · Cited by 186
Bersin, R. M., Wolfe, C., Kwasman, M., Lau, D., Klinski, C., Tanaka, K., Khorrami, P., Henderson, G. N., Marco, T. D., & Chatterjee, K. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90665-3 · Cited by 185
Insulin differentially regulates systemic and skeletal muscle vascular resistance
Baron, A. D., & Brechtel, G. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.1.e61 · Cited by 180
Diabetes mellitus and congestive heart failure
SOLANG, L. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1472 · Cited by 176
Why does the myocardium fail? Insights from basic science
Bristow, M. R. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90311-7 · Cited by 169
Myocardial composition and function in diabetes. The effects of chronic insulin use.
Regan, T. J., Wu, C. F., Yeh, C. K., Oldewurtel, H. A., & Haider, B. (1981) · Circulation Research · doi:10.1161/01.res.49.6.1268 · Cited by 160
Incidence of heart failure in 2,737 older persons with and without diabetes mellitus
Aronow, W. S., & Ahn, C. (1999) · Chest · doi:10.1378/chest.115.3.867 · Cited by 144
Struthers, A. D., & Morris, A. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08358-7 · Cited by 144
Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material
Yarom, R., Zirkin, H. J., Stämmler, G., & Rose, A. G. (1992) · The Journal of Pathology · doi:10.1002/path.1711660308 · Cited by 138
Gavras, H. P., Kremer, D., Brown, J. J., Gray, B., Lever, A. F., MACADAM, R. F., Medina, A., Morton, J. J., & Robertson, J. I. (1975) · American Heart Journal · doi:10.1016/0002-8703(75)90082-4 · Cited by 132
Primary myocardial disease in the diabetic mouse. An ultrastructural study.
Giacomelli, F., & Wiener, J. (1979) · PubMed · Cited by 114
Uniformity of captopril benefit in the SAVE study: subgroup analysis
Moyé, L. A., Pfeffer, M. A., Wun, C. C., Davis, B. R., Geltman, E. M., Hayes, D. L., Farnham, D. J., Randall, O. S., Dinh, H., Arnold, J. M. O., et al. (1994) · European Heart Journal · doi:10.1093/eurheartj/15.suppl_b.2 · Cited by 107
Panchal, A. R., Stanley, W. C., Kerner, J., & Sabbah, H. N. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90252-4 · Cited by 104
Fukunaga, Y., Itoh, H., Doi, K., Tanaka, T., Yamashita, J. K., Chun, T., Inoue, M., Masatsugu, K., Sawada, N., Saito, T., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00430-0 · Cited by 101
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Festa, A., D'Agostino, R., Hales, C. N., Mykkänen, L., & Haffner, S. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.624 · Cited by 97
Paolisso, G., Manzella, D., Rizzo, M. R., Ragno, E., Barbieri, M., Varricchio, G., & Varricchio, M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.723 · Cited by 94
Regulation of carbohydrate metabolism in ischemia and reperfusion
Lopaschuk, G. D. (2000) · American Heart Journal · doi:10.1067/mhj.2000.103919 · Cited by 93
The role of third-generation beta-blocking agents in chronic heart failure
Bristow, M. R., Roden, R. L., Lowes, B. D., Gilbert, E. M., & Eichhorn, E. J. (1998) · Clinical Cardiology · doi:10.1002/clc.4960211303 · Cited by 87
Anderson, J. L., Gilbert, E. M., OʼConnell, J. B., Renlund, D. G., Yanowitz, F. G., Murray, M., Roskelley, M., Mealey, P. C., Volkman, K., Deitchman, D., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80150-0 · Cited by 80
Nagano, M. C., & Dhalla, N. S. (1991) · The Endocrinologist · doi:10.1097/00019616-199112000-00012 · Cited by 70
Increased Transcapillary Escape Rate of Albumin in Nondiabetic Men in Response to Hyperinsulinemia
Nestler, J. E., BARLASCINI, C. O., Tetrault, G. A., Fratkin, M. J., Clore, J. N., & Blackard, W. G. (1990) · Diabetes · doi:10.2337/diab.39.10.1212 · Cited by 65
Baba, T., Shimada, K., Neugebauer, S., Yamada, D., Hashimoto, S., & Watanabe, T. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.953 · Cited by 58
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle
Eto, K., Ohya, Y., Nakamura, Y., Abe, I., & Fujishima, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01047-0 · Cited by 47
McKenna, K. Z., Smith, D., Tormey, W. P., & Thompson, C. J. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00318.x · Cited by 42
Yamamoto, Y., Yoshimasa, Y., Koh, M., Suga, J., Masuzaki, H., Ogawa, Y., Hosoda, K., Nishimura, H., Watanabe, Y., Inoue, G., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.332 · Cited by 39
Insulin stimulates epinephrine release under euglycemic conditions in humans
Tack, C. J., Lenders, J. W. M., Willemsen, J. J., van Druten, J. A. M., Thien, T., Lutterman, J. A., & Smits, P. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90251-7 · Cited by 29
Bassand, J. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060374 · Cited by 29
Bell, D. S. H., & Yumuk, V. (1997) · Endocrine Practice · doi:10.4158/ep.3.5.281 · Cited by 27
Self-citationCARDIOMYOPATHY AND HEART FAILURE IN DIABETES
Tang, W. H. W., & Young, J. B. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70226-7 · Cited by 23
β-Adrenergic Blocking Agents in Patients With Diabetes—Friend and Foe
Bell, D. S. H. (1999) · Endocrine Practice · doi:10.4158/ep.5.1.51 · Cited by 19
Self-citationDoppler echocardiographic-guided diagnosis and therapy of heart failure
Lainchbury, J. G., & Redfield, M. M. (1999) · Current Cardiology Reports · doi:10.1007/s11886-999-0043-7 · Cited by 13
Cited by
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
The Incidence of Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A., & Brown, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1879 · Cited by 812
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Metadata
- Authors
- Bell, D. S. H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-08-01
- Volume
- 26
- Issue
- 8
- Pages
- 2433-2441
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2144899887
- Cited by
- 404
- References
- 90
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.